Antimicrobial Sensitivity, Biochemical Characteristics and Biotyping of Staphylococcus saprophyticus: An Impact of Biofield Energy Treatment

By Mahendra Kumar Trivedi1, Alice Branton1, Dahryn Trivedi1, Gopal Nayak1, Sambhu Charan Mondal2, Snehasis Jana2

1. Trivedi Global Inc. 2. Trivedi Science Research Laboratory Pvt. Ltd.

Published on


Staphylococcus saprophyticus (S. saprophyticus) is a frequent cause of urinary tract infection in the young women. The current study was designed to analyze the effect of biofield energy treatment on S. saprophyticus for evaluation of its antibiogram profile, biochemical reactions pattern and biotyping characteristics. Two sets of ATCC samples were taken in this experiment and denoted as A and B. Sample A was revived and divided into two parts Group (Gr.I) (control) and Gr.II (revived); likewise, sample B was labeled as Gr.III (lyophilized). Gr. II and III were given with Mr. Trivedi’s biofield energy treatment. The control and treated groups of S. saprophyticus cells were tested with respect to antimicrobial susceptibility, biochemical reactions pattern and biotype number using MicroScan Walk-Away® system. The 50% out of twenty-eight tested antimicrobials showed significant alteration in susceptibility and 36.67% out of thirty antimicrobials showed an alteration in minimum inhibitory concentration (MIC) value of S. saprophyticus in revived treated cells (Gr. II, day 10), while no alteration was found in lyophilized treated cells (Gr. III, day 10) as compared to the control. It was also observed that overall 14.81%, out of twenty-seven biochemical reactions were altered in the revived treated group with respect to the control. Moreover, biotype number was changed in Gr. II, on day 5 (246076) and in Gr. III, on day 10 (242066), while organism along-with biotype number was also changed in Gr. II, on day 10 (342066, Staphylococcus hominis subsp. novobiosepticus) as compared to the control (242076, S. saprophyticus). The result suggested that biofield treatment has the significant impact on S. saprophyticus in revived treated cells with respect to the antimicrobial susceptibility, MIC, biochemical reactions pattern and biotype.


1. Raz R, Colodner R, Kunin CM (2005) who are you-Staphylococcus saprophyticus? Clin Infect Dis 40: 896-898.

2. Kuroda M, Yamashita A, Hirakawa H, Kumano M, Morikawa K, et al. (2005) Whole genome sequence of Staphylococcus saprophyticus reveals the pathogenesis of uncomplicated urinary tract infection. Proc Natl Acad Sci U S A 102: 13272-13277.

3. Pead L, Maskell R, Morris J (1985) Staphylococcus saprophyticus as a urinary pathogen: A six year prospective survey. Br Med J (Clin Res Ed) 291: 1157-1159.

4. Magarifuchi H, Kusaba K, Yamakuchi H, Hamada Y, Urakami T, et al. (2015) Staphylococcus saprophyticus native valve endocarditis in a diabetic patient with neurogenic bladder: A case report. J Infect Chemother 21: 695-699.

5. Hjelm E, Schwan A, Lundell-Etherden I, Sandberg T (1990) Antibody response to Staphylococcus saprophyticus in urinary tract infection. Scand J Infect Dis 22: 557-560.

6. Choi SH, Woo JH, Jeong JY, Kim NJ, Kim MN, et al. (2006) Clinical significance of Staphylococcus saprophyticus identified on blood culture in a tertiary care hospital. Diagn Microbiol Infect Dis 56: 337-339.

7. Gonzalez CM, Schaeffer AJ (1999) Treatment of urinary tract infection: what’s old, what’s new, and what works. World J Urol 17: 372-382.

8. Ginsburg I (20012) Role of lipoteichoic acid in infection and inflammation. Lancet Infect Dis 2: 171-179.

9. Gatermann S, Meyer HG, (1994) Staphylococcus saprophyticus hemagglutinin binds fibronectin. Infect Immun 62: 4556-4563.

10. Orden Martinez B, Martinez Ruiz R, Millan Perez R (2008) What are we learning about Staphylococcus saprophyticus? Enferm Infecc Microbiol Clin 26: 495-499.

11. Trivedi MK, Patil S, Shettigar H, Mondal SC, Jana S (2015) Antimicrobial susceptibility pattern and biochemical characteristics of Staphylococcus aureus: Impact of bio field treatment. J Microb Biochem Technol 7: 237-240.

12. Koithan M (2009) Introducing complementary and alternative therapies. J Nurse Pract 5: 18-20.

13. Prakash S, Chowdhury AR, Gupta A (2015) Monitoring the human health by measuring the biofield “aura”: An overview. IJAER 10: 27637-27641.

14. Trivedi MK, Patil S, Shettigar H, Gangwar M, Jana S (2015) Antimicrobial sensitivity pattern of Pseudomonas fluorescens after biofield treatment. J Infect Dis Ther 3: 222.

15. Trivedi M, S Patil (2008) Impact of an external energy on Staphylococcus epidermis [ATCC –13518] in relation to antibiotic susceptibility and biochemical reactions – An experimental study. J Accord Integr Med 4: 230-235.

16. Sances F, Flora E, Patil S, Spence A, Shinde V (2013) Impact of biofield treatment on ginseng and organic blueberry yield. Agrivita J Agric Sci 35: 22-29.

17. Nayak G, Altekar N (2015) Effect of biofield treatment on plant growth and adaptation. J Environ Health Sci 1: 1-9.

18. Trivedi MK, Patil S, Nayak G, Jana S, Latiyal O (2015) Influence of biofield treatment on physical, structural and spectral properties of boron nitride. J Material Sci Eng 4: 181.

19. Trivedi MK, Nayak G, Patil S, Tallapragada RM, Latiyal O (2015) Studies of the atomic and crystalline characteristics of ceramic oxide nano powders after bio field treatment. Ind Eng Manage 4: 161.

20. Fader RC, Weaver E, Fossett R, Toyras M, Vanderlaan J, et al. (2013) Multilaboratory study of the biomic automated well-reading instrument versus MicroScan WalkAway for reading MicroScan antimicrobial susceptibility and identification panels. J Clin Microbiol 51: 1548-1554.

21. Latham RH, Zeleznik D, Minshew BH, Schoenknecht FD, Stamm WE (1984) Staphylococcus saprophyticus beta-lactamase production and disk diffusion susceptibility testing for three beta-lactam antimicrobial agents. Antimicrob Agents Chemother 26: 670-672.

22. Hsueh PR, Hoban DJ, Carmeli Y, Chen SY, Desikan S, et al. (2011) Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. J Infect 63: 114-123.

23. Ghorbani A, Ehsanpour A, Roshanzamir N, Omidvar B (2012) Alterations in antibiotic susceptibility of urinary tract infection pathogens. J Nephropathol 1: 43-48.

24. Gupta K, Hooten TM, Naber KG, Wullt B, Colgan R, et al. (2011) International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the infectious diseases society of America and the European society for microbiology and infectious diseases. Clin Infect Dis 52: e103-e120.

25. Hovelius B, Mardh PA (1977) On the diagnosis of coagulase-negative staphylococci with emphasis on Staphylococcus saprophyticus. Acta Pathol Microbiol Scand B 85B: 427-434.

26. Jordan PA, Iravani A, Richard GA, Baer H (1980) Urinary tract infection caused by Staphylococcus saprophyticus. J Infect Dis 142: 510-515.

27. Cunha MLRS, Sinzato YK, Silveira (2004) Comparison of methods for the identification of coagulase-negative staphylococci. Mem Inst Oswaldo Cruz 99: 855-860.

28. Ferreira AM, Bonesso MF, Mondelli AL, da Cunha Mde L (2012) Identification of Staphylococcus saprophyticus isolated from patients with urinary tract infection using a simple set of biochemical tests correlating with 16S-23S interspace region molecular weight patterns. J Microbiol Methods 91: 406-411.

29. McTaggart LA, Elliott TSJ, (1989) Is resistance to novobiocin a reliable test for confirmation of the identification of Staphylococcus saprophyticus? J Med Microbiol 30: 253-266.

30. Rupp ME, Archer GL (1994) Coagulase-negative staphylococci: Pathogens associated with medical progress. Clin Infect Dis 19: 231-243.

31. Lindstrom E, Mild KH, Lundgren E (1998) Analysis of the T cell activation signaling pathway during ELF magnetic field exposure, p56lck and [Ca2+]i-measurements. Bioeletrochem Bioenerg 46: 129-137.

Cite this work

Researchers should cite this work as follows:

  • Trivedi MK, Branton A, Trivedi D, Nayak G, Mondal SC, et al. (2015) Antimicrobial Sensitivity, Biochemical Characteristics and Biotyping of Staphylococcus saprophyticus: An Impact of Biofield Energy Treatment. J Women’s Health Care 4: 271. doi:10.4172/2167-0420.1000271

  • Mahendra Kumar Trivedi; Alice Branton; Dahryn Trivedi; Gopal Nayak; Sambhu Charan Mondal; Snehasis Jana (2019), "Antimicrobial Sensitivity, Biochemical Characteristics and Biotyping of Staphylococcus saprophyticus: An Impact of Biofield Energy Treatment,"

    BibTex | EndNote